News & Events
May 16, 2019
Best Practices for Avoiding Paper Backup When Implementing Electronic Approaches to Patient-Reported Outcome Data Collection in Clinical Trials (May 16, 2019)This webinar provides an overview of the issues related to the use of paper backups in studies for which PRO data is collected electronically. Viable strategies to eliminate the necessity of a paper-backup system are provided. Presenters: Cindy Howry, MS (.assisTek) and Paul O’Donohoe, MSc (Medidata Solutions) PDF version...
December 19, 2018
In Recognition of 10th Anniversary, Raymond Woosley and Janet Woodcock Address CPAD Consortium’s 2018 Annual Meeting and Regulatory Science WorkshopAt its 10th Annual Meeting and Regulatory Science Workshop, November 13, 2018, in Bethesda, MD, C-Path’s Critical Path for Alzheimer’s Disease (CPAD) consortium hosted key stakeholders who gathered to review the progress made made over the past year and identify and prioritize regulatory science needs for Alzheimer disease (AD) and related dementias. At the meeting,......
May 10, 2018
Training on the Use of Technology to Collect Patient-Reported Outcome Data Electronically in Clinical Trials: Best Practice Recommendations from the ePRO Consortium (May 10, 2018)This webinar provides a recommended framework for training end users, including site staff and study participants, on the use of ePRO technology in clinical trials. The goal of the webinar is to promote consistent and sufficient training prior to initiating data collection. Presenters: Jenny J. Ly, PhD (ERT) and Serge Bodart, MSc (Bracket) PDF version...
November 22, 2017
HD-RSC Kick-off: Charles Sabine PresentationThe kickoff meeting for a new dedicated worldwide consortium focused on Huntington’s disease took place on November 6 and 7 in Silver Spring, Maryland. The goal of this meeting was to gather relevant stakeholders to align on the purpose and potential opportunities which could benefit from precompetitive collaboration for accelerating HD therapeutics. · The Kickoff......
November 16, 2017
FDA CDER Regulatory Science: The Importance of Partnership and ConsortiaDr. Janet Woodcock, Director of the Center for Drug Evaluation and Research within the United States Food and Drug Administration, explains how the FDA works with academic researchers, pharmaceutical companies, and other healthcare organizations to help identify scientific gaps in drug development. Find out how these partnerships and consortia improve FDA’s ability to review drugs.......